Trial intelligence / Profile preview

CLOROTEKAL vs Bupivacaine for Post-Partum Tubal Ligation

NCT03993314Phase 2Terminated

Sponsor
University of Alabama at Birmingham
Start
Aug 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of chloroprocaine, sponsored by University of Alabama at Birmingham. Started Aug 2019; status: terminated.

02

Drugs

chloroprocaine

Beyond the preview

Go deeper on NCT03993314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03993314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call